OSA’s 15th Incubator, focusing on Low Level Light Therapy (LLLT) also known as photobiomodulation (PBM) is up and running. LLLT/PBM describes the use of light therapy in the visible and near-infrared spectrum for stimulating biological responses. Extensive laboratory experiments and clinical trials have demonstrated PBM to be efficacious in tissue regeneration including the skin, muscle, nerves, bone, spinal PBM has been shown to produce an analgesic effect, anti-inflammatory effect and promote angiogenesis. The results from these controlled clinical trials and laboratory studies provides exciting and convincing evidence for the use of PBM as an efficacious, noninvasive treatment modality in the clinical setting. Many of these studies have demonstrated improved results and recovery with conditions such as traumatic brain injury, chronic wounds, spinal cord injury and many other injury models.
However, PBM has yet to be adopted by mainstream medicine. Why you ask? There are different answers based on who you ask.